4. Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF 3rd, Evans CH. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) 1996 21:271–7.
5. Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P. Pathophysiology of disk-related sciatica: I. evidence supporting a chemical component. Joint Bone Spine 2006 73:151–8.
6. Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand 1990 34:335–8.
7. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001 103:1813–8.
8. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997 336:973–9.
9. Mishra N, Pradhan K, Sahoo GD, Rohilla M, Meena M. Can hsCRP be the sole investigation for predicting the severity and outcome in women with pre‐eclampsia presenting late in pregnancy? Trop J Obstet Gynaecol 2019 36:54–60.
11. Deyo RA, Mirza SK. Clinical practice: herniated lumbar intervertebral disk. N Engl J Med 2016 374:1763–72.
13. Pedersen LM, Schistad E, Jacobsen LM, Roe C, Gjerstad J. Serum levels of the pro-inflammatory interleukins 6 (IL-6) and -8 (IL-8) in patients with lumbar radicular pain due to disc herniation: a 12-month prospective study. Brain Behav Immun 2015 46:132–6.
14. Cheng L, Fan W, Liu B, Wang X, Nie L. Th17 lymphocyte levels are higher in patients with ruptured than non-ruptured lumbar discs, and are correlated with pain intensity. Injury 2013 44:1805–10.
15. Lievre JA, Bloch-Michel H, Pean G, Uro J. L’hydrocortisone en injection locale. Rev Rhum 1953 20:310–1.
16. Heyse-Moore GH. A rational approach to the use of epidural medication in the treatment of sciatic pain. Acta Orthop Scand 1978 49:366–70.
17. Watts RW, Silagy CA. A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care 1995 23:564–9.
19. Gebhardt K, Brenner H, Sturmer T, et al. The course of high-sensitive C-reactive protein in correlation with pain and clinical function in patients with acute lumbosciatic pain and chronic low back pain: a 6 months prospective longitudinal study. Eur J Pain 2006 10:711–9.
20. Sugimori K, Kawaguchi Y, Morita M, Kitajima I, Kimura T. High-sensitivity analysis of serum C-reactive protein in young patients with lumbar disc herniation. J Bone Joint Surg Br 2003 85:1151–4.
21. Le Gars L, Borderie D, Kaplan G, Berenbaum F. Systemic inflammatory response with plasma C-reactive protein elevation in disk-related lumbosciatic syndrome. Joint Bone Spine 2000 67:452–5.
23. Benny BV, Patel MY. Predicting epidural steroid injections with laboratory markers and imaging techniques. Spine J 2014 14:2500–8.
25. Ackerman WE 3rd, Zhang JM. Serum hs-CRP as a useful marker for predicting the efficacy of lumbar epidural steroid injections on pain relief in patients with lumbar disc herniations. J Ky Med Assoc 2006 104:295–9.
26. Rannou F, Ouanes W, Boutron I, et al. High-sensitivity C-reactive protein in chronic low back pain with vertebral end-plate Modic signal changes. Arthritis Rheum 2007 57:1311–5.
29. Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Growth of spinal interventional pain management techniques: analysis of utilization trends and Medicare expenditures 2000 to 2008. Spine (Phila Pa 1976) 2013 38:157–68.
30. Schneider B, Varghis N, Kennedy DJ. Ideal corticosteroid choice for epidural steroid injections: a review of safety and efficacy. Curr Phys Med Rehabil Rep 2015 3:151–8.
31. Novak S, Nemeth WC. The basis for recommending repeating epidural steroid injections for radicular low back pain: a literature review. Arch Phys Med Rehabil 2008 89:543–52.